# Rapp Medical Systems, Inc. – FDA Inspection, Jun 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/rapp-medical-systems-inc/98eab8bb-7c27-48f0-9253-e30f4e85ab02
Source feed: FDA_Inspections

> FDA inspection 1057817 of Rapp Medical Systems, Inc., June 27, 2018. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1057817
- Company Name: Rapp Medical Systems, Inc.
- Inspection Date: 2018-06-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1275254 - 2025-07-01
- FDA Inspection 983378 - 2016-09-07
- [FDA Inspection 881182 - 2014-06-02](https://www.keypedia.com/records/fda_inspections/rapp-medical-systems-inc/74667a14-3fb8-4d73-8a88-be85b61b1379)
- FDA Inspection 798669 - 2012-09-12

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/lewis-k-antwi/8ab4f1c7-8b5b-4556-98a4-6edc3bc49470)

Company: https://www.keypedia.com/companies/rapp-medical-systems-inc/c4c060cf-0944-46d6-a46e-badc41c54906

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d